Morrison C J, Hurst S F, Bragg S L, Kuykendall R J, Diaz H, Pohl J, Reiss E
Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333.
Infect Immun. 1993 May;61(5):2030-6. doi: 10.1128/iai.61.5.2030-2036.1993.
Three dominant proteins (41, 48, and 49 kDa) were detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in purified preparations of the extracellular aspartyl proteinase (AP) of Candida albicans. All three proteins bound to the specific carboxyl proteinase ligand, pepstatin A, and were associated with maximum AP activity. The N-terminal amino acid sequence for the 48- and 49-kDa proteins matched that reported by others for AP, whereas the sequence for the 41-kDa protein was unique and was not homologous to any known protein. Time course studies demonstrated the simultaneous presence of all three proteins, supporting evidence that the 41- and 48-kDa proteins were not breakdown products of AP. Previous studies did not detect carbohydrate in SDS-polyacrylamide gels of purified AP preparations stained with periodic acid and silver, making glycosylation an unlikely explanation for the observed differences in the molecular masses of the proteins. Some monoclonal antibodies directed against the 49-kDa protein reacted with the 41- and 48-kDa proteins, indicating cross-reactive epitopes. Other monoclonal antibodies, however, reacted only with the 49-kDa protein. We conclude that three pepstatin A-binding proteins occur in purified AP preparations: two have the same amino acid N terminus as that reported for AP, whereas the third has a unique sequence. All three proteins should be considered when undertaking studies to determine the role of AP in candidal pathogenesis or when preparing specific antibodies for antigen capture assays.
通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)在白色念珠菌细胞外天冬氨酸蛋白酶(AP)的纯化制剂中检测到三种主要蛋白质(41、48和49 kDa)。这三种蛋白质均与特异性羧基蛋白酶配体胃蛋白酶抑制剂A结合,并与最大AP活性相关。48 kDa和49 kDa蛋白质的N端氨基酸序列与其他人报道的AP序列匹配,而41 kDa蛋白质的序列是独特的,与任何已知蛋白质均无同源性。时间进程研究表明所有三种蛋白质同时存在,支持了41 kDa和48 kDa蛋白质不是AP降解产物的证据。先前的研究在用高碘酸和银染色的纯化AP制剂的SDS-聚丙烯酰胺凝胶中未检测到碳水化合物,因此糖基化不太可能是观察到的蛋白质分子量差异的原因。一些针对49 kDa蛋白质的单克隆抗体与41 kDa和48 kDa蛋白质发生反应,表明存在交叉反应表位。然而,其他单克隆抗体仅与49 kDa蛋白质发生反应。我们得出结论,纯化的AP制剂中存在三种与胃蛋白酶抑制剂A结合的蛋白质:两种与报道的AP具有相同的N端氨基酸序列,而第三种具有独特序列。在进行确定AP在念珠菌发病机制中的作用的研究或制备用于抗原捕获测定的特异性抗体时,应考虑所有三种蛋白质。